We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Pfizer

News List

Indian patent office grants patent to Pfizer for Prevnar 13 expressbpd
August 23, 2017
The granting of this patent would block other manufacturers in India from supplying this vaccine
Which M&A made our best-and-worst ballot? Vote for the deals of the decade fiercepharma
August 16, 2017
Choose among 20-plus deals—big, like the GSK-Novartis asset swap, and smaller buys such as Bristol-Myers' Medarex buyout—for best and worst of the past 10 years.
EC approves Pfizer’s acute lymphoblastic leukemia treatment Besponsa pharmaceutical-technology
July 05, 2017
The European Commission (EC) has approved Pfizer’s Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukaemia (ALL) in the European Union (EU).
Roche, Pfizer and Aspen under investigation over cancer drug pricing pharmaceutical-technology
June 21, 2017
The Competition Commission of South Africa has initiated separate investigations against three global pharmaceutical companies over suspected excessive pricing of cancer medicines.

Previous page 1 2 Next page